COVID-19 vaccines being developed in China may be ready for use by the general public as early as November, the Chinese Center for Disease Control and Prevention (CDC) said.
In an interview with state TV on Monday, CDC chief biosafety expert Guizhen Wu said that China has four experimental vaccines in the third and final stage of clinical trials. She added that phase 3 clinical trials were proceeding smoothly and the vaccines could be ready for the general public in November or December.
Wu also said that she took an experimental vaccine herself in April, and that she has experienced no abnormal symptoms.
A unit of state pharmaceutical giant China National Pharmaceutical Group (Sinopharm) and US-listed Sinovac Biotech are developing the three vaccines under the state’s emergency use programme. A fourth COVID-19 vaccine being developed by CanSino Biologics was approved for use by the Chinese military in June.
The novel coronavirus emerged last year in China’s Wuhan province. It has killed more than 925,000 people.